# US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

https://mins.news/en/item/35641

- Reuters, 2026-08-28 12:40 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-lillys-mounjaro-reduce-cardiovascular-risk-2026-08-28/?link_source=ta_bluesky_link&taid=6a9181b80602a6000171f678

> Eli Lilly said the U.S. FDA has cleared Mounjaro for reducing the risk of heart attack or stroke among adults with type 2 diabetes who face a high risk of cardiovascular events.